Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
The purpose of the DACA was to assess: the Ministry of Health (MOH) data use and data quality processes; the opportunity and capacity of different levels of the health system to analyze data; health management information system (HMIS) governance; electronic HMIS deployment; the state of interoperability, and COVID-19 data capture.
Improved internet connectivity and capacity strengthening have increased timeliness and completeness of health data reporting in Timor-Leste. That makes all the difference for the country’s health officers.
An estimated 170,000 people contract TB each year in Vietnam. The new e-LMIS system helps ensure a reliable drug supply for those who need treatment.
The ministry of health tracks more than 80 indicators to guide decision making on health programs in Timor-Leste. This training helps guarantee quality of data in the system.
This report presents findings from LHSS Vietnam's international review of diagnosis-related group contracts and provides a series of evaluations and recommendations.
For the first time, Vietnam has procured TB medicines using its national social health insurance scheme.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.